The Immune Deficiency Foundation, in collaboration with, the American Academy of Asthma, Allergy and Immunology (AAAAI), conducted a national survey of the AAAAI membership concerning the treatment of patients with primary immunodeficiency (PI) and other conditions with intravenous immunoglobulin (IVIG). A total of 230 immunologists completed the IDF physician survey.